H.C. Wainwright & Co., LLC

We are pleased to have served as Co-Manager for Plug Power’s $280 Million Follow-On offering. Learn more about H.C. Wainwright and see all of our transactions online at www.hcwco.com/transactions

We are pleased to have served as the Co-Manager for Akebia Therapeutics’ $50 Million Follow-On offering. Learn more about H.C. Wainwright and see all of our transactions online at www.hcwco.com/transactions

Join HCW Senior Healthcare Analysts for an insightful virtual KOL event, Bird Flu in America: Is the Next Pandemic Brewing? on Thursday, March 20th at 10am EST. Our expert panel will dive into the latest developments on H5N1 (avian influenza), including its spread among birds and mammals and potential risks to human health, while also addressing vaccine options, treatment strategies, and key lessons from past pandemics to improve future preparedness. Register for our KOL event at https://ct.to/BJrJTNG

We are pleased to have served as the Co-Manager for Mineralys Therapeutics’ $175 Million Follow-On offering. Learn more about H.C. Wainwright and see all of our transactions online at www.hcwco.com/transactions

HCW Research Analyst Swayampakula Ramakanth (RK) will be hosting a fireside chat at the IO360 Summit on Monday, March 24th in Boston, MA. RK will be joined by Dr. Jonathan Rosenberg from Memorial Sloan Kettering Cancer Center, where they will engage in an in-depth discussion on the groundbreaking advancements in urothelial cancer treatment. The conversation will spotlight enfortumab vedotin and explore the potential of next-generation therapies, providing invaluable insights into the future of oncology care. We are thrilled to attend this dynamic event and look forward to connecting with fellow industry experts and attendees at the #IO360Summit! Institutional investors: if interested in joining, please contact your HCW representative or email corporateaccess@hcwco.com.

Join CalciMedica's CEO, A. Rachel Leheny, Ph.D., and CMO, Sudarshan Hebbar, M.D., as they sit down with Research Analyst Joe Pantginis, Ph.D., for an exclusive HCW@Home virtual fireside chat. Scheduled for March 6 at 11am EST, the discussion will focus on the company’s KOURAGE AKI trial—a clinical study evaluating CalciMedica’s calcioprene for the treatment of acute kidney injury (AKI)—following their plenary session at the AKI CRRT conference.   Don’t miss this insightful conversation! Register now at https://lnkd.in/eQJgHiJJ

As the month draws to a close, we are looking forward to the upcoming session of Biotech Breakthroughs: A Monthly Discovery Series, scheduled for the last Friday of each month. Led by Senior Healthcare Analyst Patrick Trucchio, this month’s session will spotlight innovative anti-seizure treatment approaches for epilepsy, featuring esteemed experts Dr. Nishant Shah from the Advocate Children's Hospital and Dr. Muhammad Zafar from the Duke University School of Medicine, Department of Pediatrics. Register for the Biotech Breakthroughs series at https://lnkd.in/epEUdRzw

Have you registered for the 3rd Annual Cell Therapy Conference on Tuesday, February 25th? Get ready as presenting companies showcase their latest developments within the landscape through exclusive corporate presentations and fireside chats, with an opportunity for attendees to participate in 1x1 meetings. Don’t miss out on the chance to explore the future of cell therapy! Visit https://lnkd.in/e-_tWKzT for more information.

We are pleased to have served as the Lead Manager for Solid Biosciences’ $200 Million Follow-On offering. Learn more about H.C. Wainwright and see all of our transactions online at www.hcwco.com/transactions

This Thursday, February 20th, at 10am EST, join BitFuFu’s Chief Executive Officer, Leo Lu, as he sits down with Research Analyst Kevin Dede for an insightful HCW@Home virtual fireside chat. They’ll delve into BitFuFu’s unique business model as well as the company’s strategic advantages, including its ability to leverage scale benefits in sourcing facilities, equipment, and power. Additionally, they’ll explore how BitFuFu seamlessly transitions its hashrates to self-mining operations when demand fluctuates. Register for the HCW@Home at https://lnkd.in/dqmZykmf